Tablet Release Reinvented: Robotics, Vision, and Spectral Intelligence
Content uniformity and assay are critical quality attributes for solid oral dosage forms, yet traditional wet chemistry methods are time consuming and destructive. In this webinar, we’ll showcase the automated SciYbotic Tablet Testing (TT) system that enables faster, more accurate non-destructive testing for tablet release.
The system showcases a fully automated workflow for tablet quality testing that integrates robotic handling, 3D vision, and spectroscopic analysis with the Bruker Multi Purpose Analyzer (MPA) to eliminate manual variability and enhance precision. By aligning with Process Analytical Technology (PAT) and Pharma 4.0 goals, the SciYbotic TT enables real-time predictions of API content. It supports efficient, compliant tablet release, demonstrating the transformative impact of automation in pharmaceutical manufacturing.
Learning Points
- You’ll discover how the SciYbotic Tablet Testing (TT) system enables non-destructive, real-time analysis of content uniformity and assay.
- Explore the integration of robotic handling, 3D vision, and spectroscopic analysis by Bruker MPA in a fully automated workflow.
- Learn how the system aligns with PAT and Pharma 4.0 initiatives.
- See how automation enhances precision, compliance, and efficiency in tablet release processes.
Who should attend
- Oral Solid Dose (OSD) manufacturing professionals seeking to modernize quality control.
- Quality assurance and quality control specialists focused on improving tablet release workflows.
- Senior managers, process engineers and automation leads exploring Pharma 4.0 solutions and technology transfer.
- PAT and advanced control strategy experts and leaders.
Presenter: Andrew Anderson (Consultant)
Andrew Anderson is a strategic pharma leader with extensive expertise in small molecule development and advanced analytical technologies. At GSK and Johnson & Johnson, he led the technology strategy, roadmaps, automation, and Process Analytical Technology (PAT) across R&D and commercial operations. Recognized for forging impactful government, academic, and cross-pharma partnerships, Andrew promotes innovation through cross-functional leadership and comprehensive tech implementation, delivering measurable improvements in efficiency, data integrity, and resource optimization.
Presenter: Matt Jones (Account Manager, SciY)
Matt Jones is a seasoned automation specialist with over 20 years of experience delivering engineered solutions across highly regulated sectors, including pharmaceuticals, biotechnology, and advanced manufacturing. His work frequently involves the application of process analytical technology (PAT) within custom automation systems designed to meet stringent industry standards.
With a strong foundation in vision systems and robotics engineering, Matt has deep expertise in machine integration, control architecture, and data-driven process optimization. He excels at translating complex requirements into scalable, compliant automation platforms that enhance throughput, quality, and traceability.Presenter: Holger Lutz (Business Unit Manager Chemistry, Pharma & Process Applied Spectroscopy - Bruker Optics GmbH & Co. KG)
PhD in Chemistry at University of Karlsruhe, Germany, focus on Analytical Chemistry. Starting 2002 as a NIR sales person at Bruker Optics. In 2007, took over the sales responsibility of PAT solutions in Germany. In parallel, built up a global sales and support infrastructure for PAT. Since 2018, is business unit manager of the newly created business unit “Chemistry, Pharma & Process”. In this function, is involved in the product management of the new PAT analyzers and related software, supports the global sales & application team, and is the main contact for Key Accounts.
